Marta Jarlier

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis

Wilhem Leconet, Myriam Chentouf, Stanislas du Manoir et al. · Clinical Cancer Research · 2016 · 108 citations · Full text

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

D. Azria, J. Doyen, Marta Jarlier et al. · Annals of Oncology · 2017 · 105 citations · Full text

Surgical Oncology, Intermediate-risk Rectal Cancer, Radiation Therapy +8

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

Wilhem Leconet, Christel Larbouret, Thierry Chardès et al. · Oncogene · 2013 · 104 citations · Full text

Preclinical Validation, Pancreatic Cancer, Axl Receptor +5

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies

Yahya Ashraf, Hanane Mansouri, Valérie Laurent‐Matha et al. · Journal for ImmunoTherapy of Cancer · 2019 · 90 citations · Full text

Effect of cigarette smoke on gustatory sensitivity, evaluation of the deficit and of the recovery time-course after smoking cessation

Fabrice Chéruel, Marta Jarlier, H Sancho-Garnier · Tobacco Induced Diseases · 2017 · 89 citations · Full text